| Title: |
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma |
| Authors: |
Beckermann, Kathryn E.Aff1; Patnaik, AmitaAff2; Winer, IraAff3; Tan, WinstonAff4; Bashir, BabarAff5; Kyriakopoulos, Christos E.Aff6; Sweis, Randy F.Aff7; Chamberlain, MarcAff8; Rini, Brian I.Aff1, IDs10637024014191_cor9 |
| Source: |
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 42(2):179-184 |
| Database: |
Springer Nature Journals |